Chronic Effects and Biological Upshots of Cannabis Use

Add to your list(s) Download to your calendar using vCal

• Ronald Berger, Assistant Professor, Whitaker Biomedical Engineering Institute, School of Medicine, Johns Hopkins University
• Thursday 25 July 2013, 10:00-11:30
• Jock Colville Hall, Churchill College, University of Cambridge.

If you have a question about this talk, please contact Khaled O. Zimmermann.

Although there are over 300 cannabinoid or cannabinoid-related compounds reported as natural constituents of Cannabis (Turner, et al., 1980) most strains of marihuana are characterized by the production of a biogenetically related series of compounds (Figure 1). Cannabinoids are terpenophenolic compounds believed to originate in the plant from condensation of a terpene derivative (such as geranyl pyrophosphate) with the phenol olivetol (as olivetolic acid) to form the cannabinoid series which includes cannabigerolic acid (CBGA), cannabichromenic acid (CBCA), cannabidiolic acid (CBDA), and Δ⁹-tetrahydrocannabinolic acid (Δ⁹-THCA) (Mechoulam, 1970; Shoyama, et al., 1975). These cannabinoids occur naturally predominantly in their water-soluble acid forms but are readily decarboxylated to their water-insoluble neutral forms by mild heating or drying of plant tissues or extracts.

This talk is part of the Cambridge University Engineering Society series.

This talk is included in these lists:

• Cambridge University Engineering Society
• Jock Colville Hall, Churchill College, University of Cambridge

Note that ex-directory lists are not shown.